Literature DB >> 17179487

Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.

David M Werny1, Trevor Thompson, Mona Saraiya, David Freedman, Benny J Kottiri, Robert R German, Mark Wener.   

Abstract

BACKGROUND: Recent studies have shown a negative association between body mass index (BMI) and prostate-specific antigen (PSA), a commonly used serum marker for the detection and diagnosis of prostate cancer. We have examined the association between several anthropometric measures and PSA in a nationally representative sample of men.
METHODS: We analyzed data from the 2001-2004 National Health and Nutrition Examination Survey. Participants in this study were men ages >or=40 years without previously diagnosed prostate cancer who had PSA measured. Height, weight, waist circumference, BMI, triceps skinfold, subscapular skinfold, and calculated total body water were examined categorically by quintiles using multiple linear regression models. All tests of significance were two sided.
RESULTS: Among white men, we report a trend for decreasing PSA with increasing weight, BMI, waist circumference, triceps skinfold thickness, and calculated total body water. Among Mexican American men, we found a trend for decreasing PSA with increasing BMI, and among black men we found a trend for decreasing PSA with increasing triceps thickness. None of the interaction terms between race/ethnicity and any of the anthropometric measures were statistically significant. Controlling for age and race/ethnicity in the multiple linear regression model, we found moderate declines in PSA with a 1 SD increase in BMI [5.9% decrease (95% confidence interval, -9.0% to -2.8%) in geometric mean PSA per 5.2-unit increase], weight [5.9% decline (-8.8% to -2.8%) per 17.7-kg increase], waist circumference [6.6% decline (-9.4% to -3.6%) per 13.4-cm increase], triceps skinfold [5.4% decline (-8.9% to -1.8%) per 6.4-mm increase], and calculated total body water [5.7% decline (-8.9% to -2.4%) per 6.5-liter increase].
CONCLUSION: Our population-based, nationally representative results expand the validity of previous studies on obesity and PSA. Higher weight, BMI, waist circumference, triceps skinfold, and total body water are associated with moderately lower PSA values. A prospective study is needed to verify whether this association affects the accuracy of the PSA test in obese men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179487     DOI: 10.1158/1055-9965.EPI-06-0588

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

1.  Association between smoking status, and free, total and percent free prostate specific antigen.

Authors:  Jun Li; Trevor Thompson; Djenaba A Joseph; Viraj A Master
Journal:  J Urol       Date:  2012-02-14       Impact factor: 7.450

2.  Body mass index affects the diagnosis and progression of prostate cancer in Hispanics.

Authors:  Rosa Negrón; Andrea Vásquez; Mariely Nieves; Lourdes Guerrios; Margarita Irizarry-Ramírez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

3.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

4.  Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population.

Authors:  Luke E Pater; Kimberly W Hart; Brian J Blonigen; Christopher J Lindsell; William L Barrett
Journal:  Am J Clin Oncol       Date:  2012-10       Impact factor: 2.339

5.  Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

Authors:  Keisuke Goto; Hirotaka Nagamatsu; Jun Teishima; Yuki Kohada; Shinsuke Fujii; Yoshimasa Kurimura; Koji Mita; Masanobu Shigeta; Satoshi Maruyama; Yoji Inoue; Mitsuru Nakahara; Akio Matsubara
Journal:  Mol Clin Oncol       Date:  2017-04-10

6.  The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.

Authors:  Lionel L Bañez; Simone Albisinni; Stephen J Freedland; Andrea Tubaro; Cosimo De Nunzio
Journal:  World J Urol       Date:  2012-07-31       Impact factor: 4.226

7.  Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk.

Authors:  Sarah J Lewis; Ali Murad; Lina Chen; George Davey Smith; Jenny Donovan; Tom Palmer; Freddie Hamdy; David Neal; J Athene Lane; Michael Davis; Angela Cox; Richard M Martin
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

8.  Has blood volume an impact on serum PSA levels?

Authors:  Anton Ponholzer; Christian Temml; Stephan Madersbacher
Journal:  World J Urol       Date:  2009-08-27       Impact factor: 4.226

9.  Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004).

Authors:  Niyati Parekh; Yong Lin; Stephen Marcella; Ashima K Kant; Grace Lu-Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

10.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.